Clinical Trials Logo

Constipation clinical trials

View clinical trials related to Constipation.

Filter by:

NCT ID: NCT02354820 Completed - Constipation Clinical Trials

Child Health Improvement Through Computer Automation of Constipation Management in Primary Care

CHICA-GI
Start date: February 2015
Phase: N/A
Study type: Interventional

This project seeks to expand an existing computerized decision support system used in pediatric primary care. The expanded system will add a module that helps clinicians recognize constipated children and then provides evidence-based reminders for constipation management, as well as automates patient educational materials. The current system is deployed across multiple sites, and the constipation module will be randomized to deployment in different sites. The difference in constipation management and patient outcomes will then be compared between sites receiving the intervention and sites not receiving the intervention over a 12 month period.

NCT ID: NCT02344485 Recruiting - Parkinson's Disease Clinical Trials

Effect of Osteopathic Manipulative Medicine on Constipation in Parkinson's Disease

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

The aim of this pilot study is to investigate the effect of Osteopathic Manipulative Medicine (OMM) in decreasing constipation symptoms in people with Parkinson's disease (PD). A second but optional aim is to determine if OMM changes the bacterial flora of the mouth and gut. OMM is a safe and gentle manual treatment provided by osteopathic physicians. All participants will receive OMM during the second half of the eleven week trial.

NCT ID: NCT02343978 Completed - Clinical trials for Chronic Constipation

Phase II Study of KWA-0711 in Patients With Chronic Constipation (CC)

Start date: December 26, 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of KWA-0711 in Chronic Constipation (CC) patients.

NCT ID: NCT02337413 Withdrawn - Nocturnal Enuresis Clinical Trials

Urotherapy vs. Urotherapy With Constipation Treatment for Nocturnal Enuresis

Start date: June 2020
Phase: Phase 4
Study type: Interventional

Constipation treatment has been found to ameliorate symptoms in some patients with nocturnal enuresis (bed wetting at night). This study aims to explore if treatment of patients without overt constipation (As defined by the ROME III criteria) will also respond to stool softening and GI behavioral therapy with reduction of their urinary tract symptoms when added to standard urotherapy.

NCT ID: NCT02336906 Withdrawn - Diurnal Enuresis Clinical Trials

Urotherapy vs. Urotherapy With Constipation Treatment for Children With Lower Urinary Tract Dysfunction

Start date: January 2020
Phase: Phase 4
Study type: Interventional

Constipation treatment has been found to ameliorate symptoms in some patients with lower urinary tract dysfunction (including day time or combined day time/night time urinary incontinence). This study aims to explore if treatment of patients without overt constipation (As defined by the ROME III criteria) will also respond to anti-constipation treatment with reduction of their urinary tract symptoms. Assessment of severity and response of lower urinary tract dysfunction will be based on the Vancouver NULTD/DES questionnaire.

NCT ID: NCT02321124 Completed - Clinical trials for Chronic Constipation

Connective Tissue Manipulation Improves Symptoms and Quality of Life in Patients With Chronic Constipation

Start date: August 2012
Phase: N/A
Study type: Interventional

Connective tissue manipulation (CTM) is a manual reflex therapy, which increases intestinal motility by stimulating autonomic nervous system to re-balance the parasympathetic and sympathetic functions. However, there is no randomized controlled trial (RCT) regarding the efficacy of CTM on constipation. This study was planned to investigate the effects of CTM in patients with chronic constipation. Patients who have diagnosis of chronic constipation according to Rome III criteria were recruited and randomized to intervention and control group. The intervention group received CTM in addition to the lifestyle advice, while the control group was given only lifestyle advice for constipation. All assessments were performed at baseline and at the end of 4 weeks. The primary outcome measure was the Constipation Severity Instrument (CSI). Secondary outcomes included Patient Assessment of Constipation Quality of Life Questionnaire (PAC-QOL), Bristol Stool Scale (BSS) and 7-day bowel diary. Differences between groups were analyzed with t-tests, Mann-Whitney U test and Chi-square test.

NCT ID: NCT02316899 Completed - Clinical trials for Irritable Bowel Syndrome With Constipation (IBS-C)

Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

Start date: October 21, 2014
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the efficacy and safety of ASP0456 in patients with constipation predominant irritable bowel syndrome (IBS-C).

NCT ID: NCT02314936 Completed - Clinical trials for Functional Constipation

Dose-ranging Efficacy of Polydextrose Supplement on Colonic Transit Time and Symptoms in Adults With Functional Constipation

Start date: April 2015
Phase: Phase 2
Study type: Interventional

This study will investigate the effectiveness of Polydextrose, a dietary fiber, at decreasing Colonic Transit Time and the gastrointestinal symptoms of Functional Constipation. One quarter of the subjects will receive 12 g of Polydextrose daily, one quarter will receive 8 g of Polydextrose daily, one quarter will receive 4 g of Polydextrose daily and one quarter will receive a placebo daily.

NCT ID: NCT02301221 Active, not recruiting - Clinical trials for Slow Transit Constipation

Effect of Fecal Microbiota Transplantation in Slow Transit Constipation

FMTSTC
Start date: March 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effect of fecal microbiota transplantation in adults with slow transit constipation.

NCT ID: NCT02292459 Withdrawn - Constipation Clinical Trials

Efficacy and Safety of Polyethylene Glycol 3350 (PEG 3350) for Relief of Constipation (MK-8114-005)

Start date: December 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the complete resolution of constipation in participants taking PEG 3350 compared to those taking PEG 4000, based on analysis of the number of bowel movements from self-reported bowel movement (BM) data. The complete resolution of constipation is defined as the elimination of straining or of hard/lumpy stools.